Authors: | Borchmann, P.; Morschhauser, F.; Dahiya, S.; Palomba, M. L.; García-Sancho, A. M.; Ortega, J. L. R.; Kuruvilla, J.; Jäger, U.; Cartron, G.; Izutsu, K.; Dreyling, M.; Kahl, B.; Ghesquieres, H.; Ardeshna, K.; Goto, H.; Barbui, A. M.; Abramson, J. S.; Fleury, I.; Mielke, S.; Farazi, T.; Fasan, O.; Lymp, J.; Vedal, M.; Nishii, R.; Avilion, A.; Papuga, J.; Nastoupil, L. J. |
Abstract Title: | TRANSCEND FL: Phase 2 study results of lisocabtagene maraleucel (liso-cel) in patients (pts) with relapsed/refractory (R/R) follicular lymphoma (FL) |
Meeting Title: | 36. Deutscher Krebskongress - Fortschritt gemeinsam gestalten |
Journal Title: | Oncology Research and Treatment |
Volume: | 47 |
Issue: | Suppl. 1 |
Meeting Dates: | 2024 Feb 21-24 |
Meeting Location: | Berlin, Germany |
ISSN: | 2296-5270 |
Publisher: | S. Karger AG |
Date Published: | 2024-02-01 |
Start Page: | 142 |
End Page: | 143 |
Language: | English |
ACCESSION: | WOS:001332646400336 |
PROVIDER: | wos |
DOI: | 10.1159/000535363 |
Notes: | Meeting Abstract: 262 -- 'The 36th German Cancer Congress - Building Progress Together' -- Located in the section 'Novel Therapeutics: Targeted Therapies, Immunotherapies, Cellular Therapies' -- Source: Wos |